Actiq

Fentanyl

Actiq is a “narcotic lollipop” given to patients for fast-acting relief from severe, debilitating pain. Actiq contains fentanyl, a highly addictive substance that is 80 times as potent as morphine. The Drug Enforcement Administration (DEA) classifies fentanyl as a Schedule II substance, meaning it has the highest potential for abuse and associated risk of fatal overdose, and puts the substance in the same category as opium, cocaine and methamphetamine.

The drug acts quickly, providing relief within 15 minutes of consuming the fentanyl lozenge.

Actiq has been associated with the following adverse events:

• 127 deaths, including two children who confused the drug for candy
• 47 overdoses or other misuse
• 91 serious, nonfatal incidents, ranging from respiratory distress to severe dehydration

The most threatening danger of the misuse of Actiq is death by respiratory failure. However, the potential for addiction also exists. Addiction, dependence and tolerance are three different consequences of the use of opiates. Addiction is the “compulsive physiological and psychological need for a habit-forming substance.” Dependence and tolerance are also present in addicted patients. Dependence is described as a “physical dependence,” where the body will develop withdrawal symptoms upon stopping the substance. Tolerance is defined as “diminution in the response to a drug after prolonged use.”

Chronic pain can be caused by many different disorders. Anyone suffering from chronic pain should consult their doctor about the dangers of using Actiq. For all patients using Actiq, it is imperative to keep Actiq lollipops, which a child could mistake for candy, stored in a safe, childproof area of one’s home.